Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Oral Semaglutide in Hyperglycaemic Patients After Renal Transplantation
Conditions
Interventions
Semaglutide 14 MG [Rybelsus]
Placebo
Locations
1
Denmark
Department og Nephrology and Endocrinology, Rigshospitalet
Copenhagen, Denmark
Start Date
September 19, 2024
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
December 29, 2025
NCT05398783
NCT07224321
NCT01399385
NCT07222137
NCT07340320
NCT07457580
Lead Sponsor
Rigshospitalet, Denmark
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions